EID1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
fibroblast	39 studies	62% ± 23%	Explore
endothelial cell	38 studies	54% ± 23%	Explore
natural killer cell	36 studies	38% ± 12%	Explore
B cell	34 studies	34% ± 10%	Explore
CD8-positive, alpha-beta T cell	31 studies	41% ± 17%	Explore
pericyte	30 studies	66% ± 22%	Explore
CD4-positive, alpha-beta T cell	30 studies	42% ± 14%	Explore
T cell	29 studies	39% ± 16%	Explore
macrophage	29 studies	36% ± 12%	Explore
conventional dendritic cell	28 studies	50% ± 16%	Explore
regulatory T cell	26 studies	48% ± 13%	Explore
smooth muscle cell	25 studies	66% ± 22%	Explore
classical monocyte	24 studies	41% ± 13%	Explore
non-classical monocyte	23 studies	41% ± 14%	Explore
dendritic cell	22 studies	46% ± 22%	Explore
plasmacytoid dendritic cell	22 studies	53% ± 15%	Explore
endothelial cell of lymphatic vessel	20 studies	64% ± 13%	Explore
memory B cell	20 studies	32% ± 8%	Explore
connective tissue cell	19 studies	66% ± 23%	Explore
mast cell	18 studies	40% ± 16%	Explore
mature NK T cell	18 studies	38% ± 10%	Explore
basal cell	18 studies	49% ± 21%	Explore
monocyte	17 studies	39% ± 11%	Explore
naive B cell	17 studies	31% ± 7%	Explore
gamma-delta T cell	17 studies	43% ± 14%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	16 studies	36% ± 10%	Explore
ciliated cell	16 studies	56% ± 14%	Explore
epithelial cell	16 studies	50% ± 24%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	42% ± 10%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	14 studies	39% ± 13%	Explore
plasma cell	14 studies	36% ± 12%	Explore
capillary endothelial cell	14 studies	47% ± 18%	Explore
CD16-negative, CD56-bright natural killer cell, human	13 studies	41% ± 12%	Explore
mucosal invariant T cell	13 studies	37% ± 10%	Explore
myofibroblast cell	13 studies	74% ± 15%	Explore
endothelial cell of artery	13 studies	54% ± 19%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	45% ± 15%	Explore
astrocyte	12 studies	38% ± 21%	Explore
vein endothelial cell	12 studies	56% ± 18%	Explore
myeloid cell	12 studies	38% ± 17%	Explore
CD4-positive, alpha-beta memory T cell	11 studies	45% ± 13%	Explore
glutamatergic neuron	11 studies	34% ± 15%	Explore
endothelial cell of vascular tree	11 studies	54% ± 20%	Explore
plasmablast	10 studies	41% ± 23%	Explore
effector memory CD8-positive, alpha-beta T cell	10 studies	45% ± 13%	Explore
mesothelial cell	10 studies	66% ± 23%	Explore
oligodendrocyte	10 studies	32% ± 14%	Explore
secretory cell	9 studies	58% ± 12%	Explore
platelet	9 studies	24% ± 6%	Explore
abnormal cell	9 studies	51% ± 23%	Explore
neuron	9 studies	54% ± 28%	Explore
hematopoietic stem cell	9 studies	62% ± 24%	Explore
type I pneumocyte	8 studies	50% ± 16%	Explore
innate lymphoid cell	8 studies	35% ± 9%	Explore
club cell	8 studies	54% ± 19%	Explore
goblet cell	8 studies	29% ± 15%	Explore
microglial cell	8 studies	28% ± 13%	Explore
oligodendrocyte precursor cell	8 studies	44% ± 24%	Explore
type II pneumocyte	7 studies	45% ± 16%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	49% ± 19%	Explore
leukocyte	7 studies	40% ± 10%	Explore
epithelial cell of proximal tubule	7 studies	42% ± 17%	Explore
progenitor cell	7 studies	59% ± 21%	Explore
retinal rod cell	7 studies	46% ± 22%	Explore
precursor B cell	7 studies	44% ± 15%	Explore
T follicular helper cell	7 studies	41% ± 8%	Explore
GABAergic neuron	7 studies	34% ± 9%	Explore
interneuron	7 studies	44% ± 22%	Explore
hematopoietic precursor cell	6 studies	60% ± 28%	Explore
ionocyte	6 studies	51% ± 9%	Explore
respiratory goblet cell	6 studies	49% ± 19%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	54% ± 23%	Explore
kidney loop of Henle epithelial cell	6 studies	50% ± 12%	Explore
renal alpha-intercalated cell	6 studies	61% ± 15%	Explore
amacrine cell	6 studies	49% ± 25%	Explore
retinal cone cell	6 studies	57% ± 27%	Explore
glial cell	6 studies	51% ± 24%	Explore
erythrocyte	6 studies	37% ± 20%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	51% ± 16%	Explore
alveolar macrophage	5 studies	27% ± 4%	Explore
CD4-positive helper T cell	5 studies	31% ± 9%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	37% ± 12%	Explore
exhausted T cell	5 studies	59% ± 12%	Explore
mononuclear phagocyte	5 studies	50% ± 17%	Explore
kidney distal convoluted tubule epithelial cell	5 studies	67% ± 16%	Explore
enteroendocrine cell	5 studies	59% ± 21%	Explore
retinal ganglion cell	5 studies	72% ± 28%	Explore
pro-B cell	5 studies	51% ± 12%	Explore
brush cell	5 studies	44% ± 18%	Explore
double negative thymocyte	5 studies	61% ± 15%	Explore
central memory CD8-positive, alpha-beta T cell	4 studies	37% ± 13%	Explore
deuterosomal cell	4 studies	25% ± 6%	Explore
pancreatic A cell	4 studies	85% ± 7%	Explore
type B pancreatic cell	4 studies	82% ± 10%	Explore
glomerular endothelial cell	4 studies	53% ± 13%	Explore
podocyte	4 studies	78% ± 11%	Explore
OFF-bipolar cell	4 studies	58% ± 25%	Explore
ON-bipolar cell	4 studies	59% ± 24%	Explore
erythroblast	4 studies	55% ± 26%	Explore
megakaryocyte	4 studies	44% ± 8%	Explore
neuroendocrine cell	4 studies	89% ± 3%	Explore
immature B cell	4 studies	49% ± 19%	Explore
retina horizontal cell	4 studies	60% ± 19%	Explore
retinal pigment epithelial cell	4 studies	49% ± 29%	Explore
adventitial cell	4 studies	70% ± 13%	Explore
mucus secreting cell	4 studies	37% ± 14%	Explore
Mueller cell	4 studies	61% ± 19%	Explore
muscle cell	4 studies	41% ± 25%	Explore
intermediate monocyte	4 studies	50% ± 22%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	48% ± 10%	Explore
granulocyte	4 studies	43% ± 13%	Explore
megakaryocyte-erythroid progenitor cell	4 studies	70% ± 26%	Explore
T-helper 17 cell	4 studies	45% ± 18%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	51% ± 20%	Explore
duct epithelial cell	3 studies	54% ± 5%	Explore
precursor cell	3 studies	70% ± 19%	Explore
pancreatic D cell	3 studies	88% ± 10%	Explore
enterocyte	3 studies	21% ± 3%	Explore
intestinal crypt stem cell	3 studies	29% ± 4%	Explore
neural crest cell	3 studies	81% ± 15%	Explore
retinal bipolar neuron	3 studies	74% ± 21%	Explore
GABAergic amacrine cell	3 studies	37% ± 10%	Explore
glycinergic amacrine cell	3 studies	38% ± 12%	Explore
renal principal cell	3 studies	51% ± 6%	Explore
lymphocyte	3 studies	56% ± 6%	Explore
Schwann cell	3 studies	54% ± 30%	Explore
serous secreting cell	3 studies	37% ± 7%	Explore
intraepithelial lymphocyte	3 studies	47% ± 13%	Explore
rod bipolar cell	3 studies	64% ± 18%	Explore
acinar cell	3 studies	42% ± 22%	Explore
cardiac muscle cell	3 studies	24% ± 7%	Explore
germinal center B cell	3 studies	32% ± 4%	Explore
myoepithelial cell	3 studies	57% ± 16%	Explore
pancreatic ductal cell	3 studies	77% ± 8%	Explore
granulocyte monocyte progenitor cell	3 studies	46% ± 26%	Explore
neutrophil	3 studies	23% ± 4%	Explore
hepatocyte	3 studies	41% ± 30%	Explore
group 3 innate lymphoid cell	3 studies	54% ± 12%	Explore
keratinocyte	3 studies	25% ± 6%	Explore
T-helper 1 cell	3 studies	58% ± 13%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	46% ± 5%	Explore
progenitor cell of mammary luminal epithelium	3 studies	34% ± 10%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	18 studies	44% ± 12%	Explore
lung	17 studies	48% ± 18%	Explore
brain	16 studies	32% ± 12%	Explore
eye	10 studies	48% ± 22%	Explore
intestine	9 studies	46% ± 21%	Explore
kidney	9 studies	45% ± 16%	Explore
pancreas	5 studies	64% ± 28%	Explore
liver	5 studies	41% ± 23%	Explore
lymph node	5 studies	44% ± 11%	Explore
placenta	4 studies	28% ± 18%	Explore
bone marrow	4 studies	43% ± 15%	Explore
uterus	4 studies	68% ± 7%	Explore
breast	4 studies	44% ± 4%	Explore
heart	3 studies	29% ± 11%	Explore
adrenal gland	3 studies	33% ± 5%	Explore
esophagus	3 studies	43% ± 34%	Explore
skin	3 studies	36% ± 11%	Explore
thymus	3 studies	60% ± 32%	Explore
adipose	3 studies	25% ± 13%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
brain	100%	12403.14	2638 / 2642	100%	486.48	705 / 705
thymus	100%	8797.73	652 / 653	100%	424.92	604 / 605
adrenal gland	100%	13001.78	258 / 258	100%	492.71	229 / 230
prostate	100%	9492.81	244 / 245	100%	386.01	501 / 502
kidney	100%	6827.01	89 / 89	99%	304.19	893 / 901
breast	100%	9786.41	459 / 459	99%	271.56	1104 / 1118
uterus	100%	11975.45	170 / 170	99%	195.74	453 / 459
ovary	100%	11136.26	180 / 180	99%	163.38	424 / 430
lung	99%	7070.59	573 / 578	99%	208.59	1145 / 1155
bladder	100%	10584.62	21 / 21	98%	168.45	492 / 504
esophagus	99%	9638.07	1428 / 1445	96%	124.89	175 / 183
stomach	99%	6705.40	356 / 359	95%	126.83	271 / 286
intestine	100%	10130.82	965 / 966	94%	129.55	494 / 527
skin	95%	7278.92	1719 / 1809	94%	297.40	445 / 472
pancreas	89%	2983.12	292 / 328	99%	230.29	176 / 178
liver	94%	3166.40	212 / 226	93%	132.15	378 / 406
adipose	100%	10610.07	1204 / 1204	0%	0	0 / 0
blood vessel	100%	17523.73	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	214.13	29 / 29
spleen	100%	6348.90	241 / 241	0%	0	0 / 0
ureter	0%	0	0 / 0	100%	110.46	1 / 1
muscle	100%	7360.36	801 / 803	0%	0	0 / 0
tonsil	0%	0	0 / 0	98%	151.38	44 / 45
heart	97%	11631.74	833 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	96%	223.40	77 / 80
peripheral blood	46%	2781.88	426 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

IV. Literature review

[source]

Gene name	EID1
Protein name	EP300 interacting inhibitor of differentiation 1 EP300-interacting inhibitor of differentiation 1 (21 kDa pRb-associated protein) (CREBBP/EP300 inhibitory protein 1) (E1A-like inhibitor of differentiation 1) (EID-1)
Synonyms	C15orf3 PTD014 RBP21 PNAS-22 CRI1
Description	FUNCTION: Interacts with RB1 and EP300 and acts as a repressor of MYOD1 transactivation. Inhibits EP300 and CBP histone acetyltransferase activity. May be involved in coupling cell cycle exit to the transcriptional activation of genes required for cellular differentiation. May act as a candidate coinhibitory factor for NR0B2 that can be directly linked to transcription inhibitory mechanisms. .
Accessions	H0YN68 ENST00000530028.3 [Q9Y6B2-1] ENST00000560490.1 Q9Y6B2

GO_0030154	Biological process	cell differentiation
GO_0000122	Biological process	negative regulation of transcription by RNA polymerase II
GO_0045892	Biological process	negative regulation of DNA-templated transcription
GO_0005654	Cellular component	nucleoplasm
GO_0036464	Cellular component	cytoplasmic ribonucleoprotein granule
GO_0035035	Molecular function	histone acetyltransferase binding
GO_0003714	Molecular function	transcription corepressor activity
GO_0005515	Molecular function	protein binding

EID1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review